FDA perspective: Correlation between physical and structural properties (Q3) of lidocaine / proaine formulation and in vitro and in vivo properties of the product

Progress and challenges of CART cell therapies in autoimmune diseases

NGS! learning review: the development and principle of sequencing technology

AI pharmaceutical to start a breakthrough competition, the beginning of a new era

The next big BD password

Target protein degradation frontier: a new strategy for E3 decoding deconvolution